Drug shows promise for Ebola virus treatment in primates

For the first time, scientists have successfully treated monkeys infected with the deadly Ebola virus. Ebola causes hemorrhagic fever that kills up to 80 percent of humans infected with the virus.

These findings, published in the December 13th issue of THE LANCET, represent an important step in the search for a treatment strategy for Ebola. Currently no effective therapies are available.

In the study, Thomas W. Geisbert and colleagues from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) injected 12 rhesus macaques with Ebola virus. Nine of the animals received a drug called recombinant nematode anticoagulant protein c2 (rNAPC2), while the remaining three were untreated.

In the treatment group, monkeys received rNAPC2 either immediately after Ebola infection, or 24 hours later, and continued to receive it daily for up to fourteen days. Three of the nine monkeys survived, and death was slowed by several days in the remaining six. All three untreated animals died.

Previous attempts to use antiviral drugs to treat Ebola have demonstrated success in mice and guinea pigs, but not in primates. Geisbert's team approached the problem a different way--by focusing on the symptoms triggered by the virus, rather than the virus itself.

Ebola causes coagulopathy, or abnormal blood clotting, which ultimately leads to massive hemorrhage and death. Studies at USAMRIID suggest that macrophages, a type of white blood cell, play an important role in this process. When a host is infected with Ebola virus, the macrophages express a clotting protein, called tissue factor, on their surfaces. These cells are then attracted to the blood as it flows through the body, forming localized clots that pave the way for abnormal bleeding.

Using rNAPC2, according to Geisbert, essentially blocks the harmful effects of tissue factor. The drug is already being evaluated to treat coronary problems, and has a demonstrated p

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Page: 1 2

Related biology news :

1. New study shows hope for treating inhalant abuse
2. Chemical derived from vitamin-E shows early promise as cancer drug
3. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
4. Trial shows which brain cancer patients benefit from temozolomide
5. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
6. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
7. Simian virus 40 not associated with non-Hodgkin lymphoma, study shows
8. A probable cause for high blood pressure identified - shows links with diabetes
9. Blue marlin in gulf have high mercury levels, A&M study shows
10. New research shows air pollution can reduce childrens lung function
11. Pneumococcal vaccine reduces ear infections, pneumonia, new study shows

Post Your Comments:

(Date:4/30/2020)... ... April 28, 2020 , ... Pebble Labs USA Inc. , a ... and aquaculture with the mission of improving global food security, announced today that they ... Next Heroes in Food- and Ag-Tech ' virtual event, a global initiative to drive ...
(Date:4/30/2020)... ... April 29, 2020 , ... At ... growth – delivering innovative solutions for a wide range of industries including pharmaceutical ... agencies. A month into the new decade, it was clear to company leadership ...
(Date:4/26/2020)... ... 23, 2020 , ... SECO , a leading company ... managed by Fondo Italiano d’Investimento SGR, today announced a partnership with IBD, an ... a new non-invasive pulmonary ventilator created in response to the current health emergency ...
Breaking Biology News(10 mins):
(Date:6/2/2020)... ... June 01, 2020 , ... As part of ... change in the world, enterprise security solutions provider bitsIO donated time to help ... from home during self-quarantines and shelter-in-place orders, companies are increasingly concerned about the ...
(Date:5/28/2020)... Md. (PRWEB) , ... May 28, 2020 , ... The ... biometrics and security leaders as the 2020 winners of the Women in Biometrics ... with sponsors IDEMIA , Biometric Update and the SIA Women ...
(Date:5/21/2020)... ... 19, 2020 , ... Eaton Square is pleased to announce its growth on ... biotechnology and medical technology-focused strategy and M&A advisory firm. , This is an important ... US and Asia Pacific healthcare innovators with capital and investors. , Popper and Company, ...
(Date:5/15/2020)... ... , ... This new service offers clients a way to speak with Subject ... the need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range of ... OnCall™ SMEs are available normal business hours Monday through Friday from 9:00 am – ...
Breaking Biology Technology:
Cached News: